Clinical-pharmacological drug information center of Hannover Medical School: experiences and analysis from a tertiary care university hospital.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 11 2022
Historique:
received: 16 06 2022
accepted: 08 11 2022
pubmed: 14 11 2022
medline: 16 11 2022
entrez: 13 11 2022
Statut: epublish

Résumé

Drug information centers (DICs) are institutions dedicated to provide objective, independent, and up-to-date information on drugs and their rational use. To overcome the lack of recent DIC reports from central Europe, we analyzed all queries (n = 594) submitted to the DIC run by the Institute for Clinical Pharmacology of Hannover Medical School between October 2018 and April 2022. Approximately one in three queries (31.1%; 185/594) was submitted by internists. 82.8% (492/594) of the queries were patient-specific, while the remaining 17.2% (102/594) were general queries. Adverse drug reactions (ADRs), indications/contraindications, and pharmacodynamic interactions (PDIs) represented the three most frequently addressed query categories, being involved in 44.8% (266/594), 43.3% (257/594), and 34.3% (204/594) of all queries, respectively (assignment of more than one category per query was possible). As compared to general queries, patient-specific queries were statistically significantly more often related to ADRs, PDIs, and pharmacokinetic interactions (PKIs) (ADRs: 35.3% vs. 46.7%, P = 0.034; PDIs: 14.7% vs. 38.4%, P < 0.001; PKIs: 20.6% vs. 31.5%, P = 0.028). To demonstrate the complexity of queries submitted to the clinical-pharmacological DIC, we present and comment on an illustrative selection of queries.

Identifiants

pubmed: 36371467
doi: 10.1038/s41598-022-24005-y
pii: 10.1038/s41598-022-24005-y
pmc: PMC9653451
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19409

Informations de copyright

© 2022. The Author(s).

Références

Ther Innov Regul Sci. 2014 May;48(3):378-385
pubmed: 30235535
Sci Rep. 2019 Sep 25;9(1):13835
pubmed: 31554837
Am J Hosp Pharm. 1978 Oct;35(10):1233-7
pubmed: 696731
Toxins (Basel). 2017 Feb 25;9(3):
pubmed: 28245621
Hosp Pharm. 2017 Jul;52(7):452-453
pubmed: 29276270
Br J Clin Pharmacol. 2004 Jan;57(1):6-14
pubmed: 14678335
J Pharm Bioallied Sci. 2017 Oct-Dec;9(4):246-250
pubmed: 29456375
Eur J Clin Pharmacol. 1992;42(6):563-7
pubmed: 1623895
J Clin Pharm Ther. 2019 Jun;44(3):489-492
pubmed: 30710370
Am J Health Syst Pharm. 2005 Dec 1;62(23):2511-4
pubmed: 16303908
Ann Transl Med. 2018 Sep;6(17):335
pubmed: 30306074
Internist (Berl). 2022 Feb;63(2):217-220
pubmed: 34698875
Dtsch Arztebl Int. 2016 Sep 23;113(38):627-633
pubmed: 27743469
Eur J Clin Pharmacol. 2000 Jan;55(10):707-11
pubmed: 10663447
Am J Health Syst Pharm. 2009 Oct 1;66(19):1718-22
pubmed: 19767377
Dtsch Arztebl Int. 2010 Aug;107(31-32):543-51
pubmed: 20827352
Clin Transplant. 2020 Dec;34(12):e14088
pubmed: 32949050
Lancet. 2017 Jul 29;390(10093):490-499
pubmed: 28622955
Lancet. 1983 Dec 17;2(8364):1410-2
pubmed: 6140504
Eur J Clin Pharmacol. 2010 Oct;66(10):1037-46
pubmed: 20644922
Unfallchirurg. 2021 Feb;124(2):138-145
pubmed: 32533212
Eur J Clin Pharmacol. 2014 Nov;70(11):1395-401
pubmed: 25213372
Am J Hosp Pharm. 1985 Apr;42(4):819-26
pubmed: 4014232
Pharm World Sci. 1998 Jun;20(3):131-5
pubmed: 9618737
Pharm World Sci. 2010 Dec;32(6):799-804
pubmed: 20922480
Eur J Clin Pharmacol. 1995;49(1-2):87-9
pubmed: 8751027
Basic Clin Pharmacol Toxicol. 2019 Jul 16;:
pubmed: 31310705
J Pharm Technol. 2019 Aug;35(4):155-163
pubmed: 34861032
Antibiotics (Basel). 2022 Mar 10;11(3):
pubmed: 35326835
J Thorac Dis. 2014 Aug;6(8):1039-53
pubmed: 25132971
Int J Clin Pharmacol Ther. 1999 Jun;37(6):263-8
pubmed: 10395116
Dtsch Arztebl Int. 2021 Dec 27;118(51-52):875-882
pubmed: 34939917
Pharm World Sci. 2001 Dec;23(6):217-23
pubmed: 11826511
J Am Acad Dermatol. 2002 Nov;47(5):672-84
pubmed: 12399758
Eur J Clin Pharmacol. 1997;53(2):89-94
pubmed: 9403277
Eur J Clin Pharmacol. 2021 Feb;77(2):271-272
pubmed: 32939564
Eur J Clin Pharmacol. 1998 Sep;54(7):573-4
pubmed: 9832301
Afr Health Sci. 2011 Sep;11(3):493-8
pubmed: 22275945
Clin Pharmacol Ther. 2021 Jun;109(6):1505-1516
pubmed: 33336382
Int J Pharm Investig. 2017 Oct-Dec;7(4):182-187
pubmed: 29692977
Biomed Res Int. 2018 Aug 26;2018:3840976
pubmed: 30225252
Food Sci Biotechnol. 2018 Sep 21;28(2):609-614
pubmed: 30956874
Clin Ther. 2016 Feb;38(2):414-21
pubmed: 26831829
Neurol Clin Pract. 2014 Feb;4(1):26-33
pubmed: 29473588
Pharm Pract (Granada). 2015 Jan-Mar;13(1):524
pubmed: 25883691
Clin Pharmacol Ther. 2007 Sep;82(3):265-74
pubmed: 17344806
Transpl Int. 2004 Mar;17(3):120-5
pubmed: 14749919
J Pharm Pract. 2021 Aug;34(4):581-586
pubmed: 31726905
Eur J Clin Pharmacol. 2009 Mar;65(3):303-8
pubmed: 19052735
Eur J Clin Pharmacol. 2013 May;69 Suppl 1:65-72
pubmed: 23640190

Auteurs

Johannes Heck (J)

Institute for Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. heck.johannes@mh-hannover.de.

Dirk O Stichtenoth (DO)

Institute for Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Drug Commissioner of Hannover Medical School (Dirk O. Stichtenoth); Head of Pharmacovigilance of Hannover Medical School (Christoph Schröder), Hannover, Germany.

Ruxandra Sabau (R)

Institute for Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Christoph Schröder (C)

Institute for Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Drug Commissioner of Hannover Medical School (Dirk O. Stichtenoth); Head of Pharmacovigilance of Hannover Medical School (Christoph Schröder), Hannover, Germany.

Stefan Engeli (S)

Institute for Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Institute for Pharmacology, University Medicine Greifswald, Greifswald, Germany.

Thorben Pape (T)

Institute for Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Nina O'Connell (N)

Institute for Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Carsten Schumacher (C)

Center for Clinical Trials, Hannover Medical School, Hannover, Germany.

Olaf Krause (O)

Institute for General Practice and Palliative Care, Hannover Medical School, Hannover, Germany.
Center for Medicine of the Elderly, DIAKOVERE Henriettenstift, Hannover, Germany.

Felix Koop (F)

Institute for Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH